Biomarkers of nutrient bioactivity and efficacy: A route toward personalized nutrition

Journal of Clinical Gastroenterology

Volumn 46, Issue 7, 2012, Pages 545-554

  Rubio Aliaga, Isabel ^a   Kochhar, Sunil ^a   Silva Zolezzi, Irma ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

biomarkers; nutrient bioefficacy; nutrigenomics

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; FOLIC ACID; RETINOL; TRANSCRIPTOME; ZINC;

ANALYTIC METHOD; BIOAVAILABILITY; DIETARY INTAKE; EPIGENETICS; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HUMAN; METABOLOMICS; NUTRIENT; NUTRIGENOMICS; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PERSONALIZED NUTRITION; PRIORITY JOURNAL; PROTEOMICS; RELIABILITY; REVIEW; STANDARDIZATION;

BIOLOGICAL MARKERS; HUMANS; METABOLOMICS; NUTRIGENOMICS; NUTRITIONAL STATUS; PROTEOMICS;

EID: 84863741022     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182548df2     Document Type: Review

References (128)

1. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252.
2. Ghosh S, Dent R, Harper ME, et al. Blood gene expression reveal pathway differences between diet-sensitive and resistant obese subjects prior to caloric restriction. Obesity (Silver Spring). 2011;19:457-463.
3. Keskitalo K, Tuorila H, Spector TD, et al. The Three-Factor Eating Questionnaire, body mass index, and responses to sweet and salty fatty foods: A twin study of genetic and environmental associations. Am J Clin Nutr. 2008;88:263-271.
4. Green R. Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Am J Clin Nutr. 2011;94:666S-672S.
5. Fay LB, German JB. Personalizing foods: Is genotype necessary? Curr Opin Biotechnol. 2008;19:121-128.
6. Kussmann M, Fay LB. Nutrigenomics and personalized nutrition: Science and concept. Pers Med. 2008;5:447-455.
7. Jackson MD, Walker SP, Younger NM, et al. Use of a food frequency questionnaire to assess diets of Jamaican adults: Validation and correlation with biomarkers. Nutr J. 2011;10:28-38.
8. Prentice RL, Huang Y, Kuller LH, et al. Biomarker-calibrated energy and protein consumption and cardiovascular disease risk among postmenopausal women. Epidemiology. 2011;22: 170-179.
9. Johnson BA, Herring AH, Ibrahim JG, et al. Structured measurement error in nutritional epidemiology: Applications in the Pregnancy, Infection, and Nutrition (PIN) study. J Am Stat Assoc. 2007;102:856-866.
10. Raiten DJ, Namaste S, Brabin B, et al. Executive summary- biomarkers of nutrition for development: Building a consensus. Am J Clin Nutr. 2011;94:633S-650S.
11. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89-95.
12. Offit K. Personalized medicine: New genomics, old lessons. Hum Genet. 2011;130:3-14.
13. Schoeller DA, Hnilicka JM. Reliability of the doubly labeled water method for the measurement of total daily energy expenditure in free-living subjects. J Nutr. 1996;126:348S-354S
14. Bingham SA. The use of 24-h urine samples and energy expenditure to validate dietary assessments. Am J Clin Nutr. 1994;59:227S-231S
15. Potischman N, Freudenheim JL. Biomarkers of nutritional exposure and nutritional status: An overview. J Nutr. 2003;133(suppl 3):873S-874S.
16. Wittwer J, Rubio-Aliaga I, Hoeft B, et al. Nutrigenomics in human intervention studies: Current status, lessons learned and future perspectives. Mol Nutr Food Res. 2011;55:341-358.
17. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011;17:330-339.
18. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet. 2004;5:71-118.
19. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
20. Crider KS, Zhu JH, Hao L, et al. MTHFR 677C-T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr. 2011;93:1365-1372.
21. Ashfield-Watt PA, Pullin CH, Whiting JM, et al. Methylenetetrahydrofolate reductase 677C-T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: A randomized controlled trial. Am J Clin Nutr. 2002;76:180-186.
22. Fohr IP, Prinz-Langenohl R, Bronstrup A, et al. 5,10- Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr. 2002;75:275-282.
23. Guinotte CL, Burns MG, Axume JA, et al. Methylenetetrahydrofolate reductase 677C-T variant modulates folate status response to controlled folate intakes in young women. J Nutr. 2003;133:1272-1280.
24. Miyaki K, Murata M, Kikuchi H, et al. Assessment of tailormade prevention of atherosclerosis with folic acid supplementation: Randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype. J Hum Genet. 2005;50:241-248.
25. McNulty H, Dowey le RC, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C-T polymorphism. Circulation. 2006;113:74-80.
26. Horigan G, McNulty H, Ward M, et al. Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C-T polymorphism in MTHFR. J Hypertens. 2010;28:478-486.
27. Frazer KA, Murray SS, Schork NJ, et al. Human genetic variation and its contribution to complex traits. Nat Rev Genet. 2009;10:241-251.
28. Ragoussis J. Genotyping technologies for genetic research. Annu Rev Genomics Hum Genet. 2009;10:117-133.
29. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166-176.
30. Williams CM, Ordovas JM, Lairon D, et al. The challenges for molecular nutrition research 1: Linking genotype to healthy nutrition. Genes Nutr. 2008;3:41-49.
31. Major JM, Yu K,Wheeler W, et al. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum Mol Genet. 2011;20:3876-3883.
32. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19:2739-2745.
33. Tanaka T, Shen J, Abecasis GR, et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI study. PLoS Genet. 2009;5:e1000338.
34. Mondul AM, Yu K, Wheeler W, et al. Genome-wide association study of circulating retinol levels. Hum Mol Genet. 2011;20:4724-4731.
35. Hazra A, Kraft P, Selhub J, et al. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet. 2008;40:1160-1162.
36. Tanaka T, Scheet P, Giusti B, et al. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet. 2009;84:477-482.
37. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713.
38. Dumitrescu L, Carty CL, Taylor K, et al. Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet. 2011;7:e1002138.
39. Chung CM, Lin TH, Chen JW, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011;60:2417-2423.
40. Qi L, Menzaghi C, Salvemini L, et al. Novel locus FER is associated with serum HMW adiponectin levels. Diabetes. 2011;60:2197-2201.
41. Jee SH, Sull JW, Lee JE, et al. Adiponectin concentrations: A genome-wide association study. Am J Hum Genet. 2010;87: 545-552.
42. Wu Y, Li Y, Lange EM, et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet. 2010;19:4955-4964.
43. Richards JB, Waterworth D, O'Rahilly S, et al. A genomewide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet. 2009;5:e1000768.
44. Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: Results of genome-wide association analyses including 4659 European individuals. Atherosclerosis. 2009;208:412-420.
45. Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: The GEMS study. Obesity (Silver Spring). 2009;17:737-744.
46. Cui J, Panse S, Falkner B. The role of adiponectin in metabolic and vascular disease: A review. Clin Nephrol. 2011;75:26-33.
47. Tiaka EK, Manolakis AC, Kapsoritakis AN, et al. The implication of adiponectin and resistin in gastrointestinal diseases. Cytokine Growth Factor Rev. 2011;22:109-119.
48. Gieger C, Geistlinger L, Altmaier E, et al. Genetics meets metabolomics: A genome-wide association study of metabolite profiles in human serum. PLoS Genet. 2008;4:e1000282.
49. Suhre K, Shin SY, Petersen AK, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011;477:54-60.
50. Chambers JC, Zhang W, Lord GM, et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet. 2010;42:373-375.
51. Kottgen A, Pattaro C, Boger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010;42:376-384.
52. Mittelstrass K, Ried JS, Yu Z, et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 2011;7:e1002215.
53. Shi L, Reid LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006;24:1151-1161.
54. Malone JH, Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol. 2011;9:34-42.
55. Dawson K, Zhao L, Adkins Y, et al. Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men. J Nutr Biochem. http://dx.doi.org/10.1016/ .jnutbio.2011.03.004.
56. Camargo A, Ruano J, Fernandez JM, et al. Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics. 2010;11:253-263.
57. Bouwens M, Grootte Bromhaar M, Jansen J, et al. Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles. Am J Clin Nutr. 2010;91:208-217.
58. Konstantinidou V, Khymenets O, Covas MI, et al. Time course of changes in the expression of insulin sensitivity-related genes after an acute load of virgin olive oil. OMICS. 2009;13:431-438.
59. Khymenets O, Fito M, Covas MI, et al. Mononuclear cell transcriptome response after sustained virgin olive oil consumption in humans: An exploratory nutrigenomics study. OMICS. 2009;13:7-19.
60. van Dijk SJ, Feskens EJ, Bos MB, et al. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr. 2009;90:1656-1664.
61. Kabir M, Skurnik G, Naour N, et al. Treatment for 2mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: A randomized controlled study. Am J Clin Nutr. 2007;86:1670-1679.
62. Magbanua MJ, Roy R, Sosa EV, et al. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011;6:e24004.
63. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:e3148.
64. Davis CD, Ross SA. Evidence for dietary regulation of micro- RNA expression in cancer cells. Nutr Rev. 2008;66:477-482.
65. Kussmann M, Panchaud A, Affolter M. Proteomics in nutrition: Status quo and outlook for biomarkers and bioactives. J Proteome Res. 2010;9:4876-4887.
66. Walther TC, Mann M. Mass spectrometry-based proteomics in cell biology. J Cell Biol. 2010;190:491-500.
67. Matthiesen R. Methods, algorithms and tools in computational proteomics: A practical point of view. Proteomics. 2007;7:2815-2832.
68. Panchaud A, Affolter M, Moreillon P, et al. Experimental and computational approaches to quantitative proteomics: Status quo and outlook. J Proteomics. 2008;71:19-33.
69. Lisacek F, Cohen-Boulakia S, Appel RD. Proteome informatics II: Bioinformatics for comparative proteomics. Proteomics. 2006;6:5445-5466.
70. de Roos B, McArdle HJ. Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research. Br J Nutr. 2008;99(suppl 3):S66-S71.
71. Moller NP, Scholz-Ahrens KE, Roos N, et al. Bioactive peptides and proteins from foods: Indication for health effects. Eur J Nutr. 2008;47:171-182.
72. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature. 2008;455:1054-1056.
73. Rezzi S, Ramadan Z, Fay LB, et al. Nutritional metabonomics: Applications and perspectives. J Proteome Res. 2007; 6:513-525.
74. Rezzi S, Vera FA,Martin FP, et al. Automated SPE-RP-HPLC fractionation of biofluids combined to off-line NMR spectroscopy for biomarker identification in metabonomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;871:271-278.
75. Wishart DS. Computational strategies for metabolite identification in metabolomics. Bioanalysis. 2009;1:1579-1596.
76. Scalbert A, Brennan L, Fiehn O, et al. Mass-spectrometrybased metabolomics: Limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics. 2009;5:435-458.
77. Heinzmann SS, Merrifield CA, Rezzi S, et al. Stability and robustness of human metabolic phenotypes in response to sequential food challenges. J Proteome Res. 2012;11:643-655.
78. Nanney DL. Epigenetic control systems. Proc Natl Acad Sci USA. 1958;44:712-717.
79. Wu C, Morris JR. Genes, genetics, and epigenetics: A correspondence. Science. 2001;293:1103-1105.
80. Attig L, Gabory A, Junien C. Early nutrition and epigenetic programming: Chasing shadows. Curr Opin Clin Nutr Metab Care. 2010;13:284-293.
81. Gluckman PD, Hanson MA, Bateson P, et al. Towards a new developmental synthesis: Adaptive developmental plasticity and human disease. Lancet. 2009;373:1654-1657.
82. Gluckman PD, Hanson MA, Mitchell MD. Developmental origins of health and disease: Reducing the burden of chronic disease in the next generation. Genome Med. 2010;2:14-16.
83. Bell JT, Spector TD. A twin approach to unraveling epigenetics. Trends Genet. 2011;27:116-125.
84. Cedar H, Bergman Y. Linking DNA methylation and histone modification: Patterns and paradigms. Nat Rev Genet. 2009;10:295-304.
85. Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: Regulators of disease. J Pathol. 2010;220:126-139.
86. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28:1057-1068.
87. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 2010;11:191-203.
88. Irizarry RA, Wu H, Feinberg AP. A species-generalized probabilistic model-based definition of CpG islands. Mamm Genome. 2009;20:674-680.
89. Boyle AP, Davis S, Shulha HP, et al. High-resolution mapping and characterization of open chromatin across the genome. Cell. 2008;132:311-322.
90. Simonis M, Klous P, Splinter E, et al. Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat Genet. 2006;38:1348-1354.
91. Li Y, Daniel M, Tollefsbol TO. Epigenetic regulation of caloric restriction in aging. BMC Med. 2011;9:98-109.
92. Milagro FI, Campion J, Cordero P, et al. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J. 2011;25:1378-1389.
93. Bouchard L, Rabasa-Lhoret R, Faraj M, et al. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr. 2010;91:309-320.
94. O'Sullivan M, O'Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2006;20:561-573.
95. Mahmud N, Weir DG. The urban diet and Crohn's disease: Is there a relationship? Eur J Gastroenterol Hepatol. 2001;13: 93-95.
96. Amre DK, D'Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol. 2007;102:2016-2025.
97. Rajendran N, Kumar D. Role of diet in the management of inflammatory bowel disease. World J Gastroenterol. 2010; 16:1442-1448.
98. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458-466.
99. Lees CW, Barrett JC, Parkes M, et al. New IBD genetics: Common pathways with other diseases. Gut. 2011;60: 1739-1753.
100. Glubb DM, Gearry RB, Barclay ML, et al. NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease. World J Gastroenterol. 2011;17:2829-2837.
101. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39:596-604.
102. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-832.
103. Ferguson LR, Shelling AN, Browning BL, et al. Genes, diet and inflammatory bowel disease. Mutat Res. 2007;622: 70-83.
104. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004;36:471-475.
105. De Cruz P, Prideaux L, Wagner J, et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:372-390.
106. Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011. doi: 10.1002/ibd.21866.
107. Noor SO, Ridgway K, Scovell L, et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134-142.
108. Walker AW, Sanderson JD, Churcher C, et al. Highthroughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011;11:7-18.
109. Sokol H, Seksik P. The intestinal microbiota in inflammatory bowel diseases: Time to connect with the host. Curr Opin Gastroenterol. 2010;26:327-331.
110. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115:1405-1413.
111. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80-93.
112. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: A systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607-613.
113. Abubakar I, Myhill D, Aliyu SH, et al. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: A systematic review and meta-analysis. Inflamm Bowel Dis. 2008;14:401-410.
114. Lee G, Buchman AL. DNA-driven nutritional therapy of inflammatory bowel disease. Nutrition. 2009;25:885-891.
115. Bassaganya-Riera J, Hontecillas R. Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2010;13:569-573.
116. Werner T, Wagner SJ, Martinez I, et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's diseaselike ileitis. Gut. 2010;60:325-333.
117. Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr. 2007;137:812S-818S.
118. Yamamoto E, Toyota M, Suzuki H, et al. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis. Cancer Epidemiol Biomarkers Prev. 2008;17:2555-2564.
119. Tahara T, Shibata T, Nakamura M, et al. Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci. 2009;55:54-59.
120. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet. 2007;8:286-298.
121. Ushijima T, Nakajima T, Maekita T. DNA methylation as a marker for the past and future. J Gastroenterol. 2006;41:401-407.
122. Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 2003;52:502-506.
123. Tahara T, Arisawa T, Shibata T, et al. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion. 2007;75:54-61.
124. Dong CX, Deng DJ, Pan KF, et al. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: A population-based study. Int J Cancer. 2009;124:434-439.
125. Nakajima T, Yamashita S, Maekita T, et al. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int J Cancer. 2009;124:905-910.
126. Leung WK, Man EP, Yu J, et al. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res. 2006;12:3216-3221.
127. Miyazaki T, Murayama Y, Shinomura Y, et al. E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis. Helicobacter. 2007;12:523-531.
128. Kim YJ, Chung JW, Lee SJ, et al. Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng. J Clin Biochem Nutr. 2010;46:195-204.